A detailed history of Tower Research Capital LLC (Trc) transactions in Eterna Therapeutics Inc. Commo stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,994 shares of ERNA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,994
Previous 5,174 3.48%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-180 Reduced 3.48%
4,994 $0
Q2 2024

Aug 13, 2024

BUY
N/A
1,091 Added 26.72%
5,174 $0
Q1 2024

May 15, 2024

SELL
N/A
-326 Reduced 7.39%
4,083 $0
Q4 2023

Feb 13, 2024

SELL
N/A
-195 Reduced 4.24%
4,409 $0
Q3 2023

Nov 14, 2023

SELL
N/A
-427 Reduced 8.49%
4,604 $0
Q2 2023

Aug 14, 2023

BUY
N/A
4,986 Added 11080.0%
5,031 $0
Q1 2023

May 09, 2023

SELL
N/A
-160 Reduced 78.05%
45 $0
Q4 2022

Feb 10, 2023

BUY
N/A
205 New
205 $0

Others Institutions Holding ERNA

About ETERNA THERAPEUTICS INC. COMMO


  • Ticker ERNA
More about ERNA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.